GLP1R and type 2 diabetes mellitus: Exenatide, the first GLP-1 receptor agonist approved by the Food and Drug Administration (FDA) in 2005 for T2DM treatment, is a 39-amino acid peptide secreted by the Gila monster's salivary glands.